Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 172
Filter
1.
Child Care Health Dev ; 44(3): 378-383, 2018 05.
Article in English | MEDLINE | ID: mdl-29392794

ABSTRACT

BACKGROUND: The Griffiths Mental Development Scales (GMDS) are used in many countries to assess the development of children from birth to 8 years. There is a need for accurate and culturally appropriate developmental assessment tools for Chinese children. Here, we adapted the GMDS for use in Chinese children and compare the developmental trajectories between Chinese and British children. METHODS: Children with typical development were recruited from 7 urban cities in China between 2009 and 2013. The Griffiths Mental Development Scales-Chinese (GDS-C) were adapted and used to assess the development of urban Chinese children. Developmental curves were computed for 6 subscales using learning management system methods and compare against the British curves from the Griffiths Mental Development Scales-Extended Revised (GMDS-ER). RESULTS: The GDS-C were used to assess the developmental status of 815 Chinese children. Plots of the 1st, 5th, 10th, 25th, 50th, 75th, 90th, 95th, and 99th percentiles, and full percentile tables were obtained, which showed similar trends to data from the British GMDS-ER. CONCLUSIONS: The Chinese developmental curves obtained from the GDS-C showed similarities and differences to the developmental curves from the British GMDS-ER. The development of urban Chinese children should be assessed with the culturally appropriate GDS-C.


Subject(s)
Behavior Rating Scale , Child Development/physiology , Cross-Cultural Comparison , Child , Child, Preschool , China , Developmental Disabilities/diagnosis , Female , Humans , Infant , Infant, Newborn , Male , Reference Standards , Reproducibility of Results , United Kingdom
2.
Curr Mol Med ; 11(2): 76-92, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21342133

ABSTRACT

Stroke is one of the leading causes of death and disability worldwide. There are two major types of stroke: cerebral ischemia caused by obstruction of blood vessels in the brain and haemorrhagic stroke that is triggered by the disruption of blood vessels. Thrombolytic therapy involving recombinant tissue plasminogen activator (rtPA) has been shown to be beneficial only when used within 4.5 hours of onset of acute ischemic stroke. rtPA treatment beyond this time window has been found to be unsuitable and usually resulting in haemorrhagic transformation. Stroke is a multifactorial disease that forms a possible end state for majority of patients suffering from diabetes, atherosclerosis and hypertension which are known risk factors. Although the biochemistry of stroke and related diseases is quite well understood, the knowledge on the molecular mechanisms underlying these diseases is still at its infancy. microRNAs that form a unique class of endogenous riboregulators of gene function, offer tremendous potential in unraveling the mechanisms underlying stroke pathogenesis. microRNA expression also reflects the response of individuals to drugs and therapy. Several microRNAs and their target genes, known to be involved in endothelial dysfunction, dysregulation of neurovascular integrity, edema formation, pro-apoptosis, inflammation and extra-cellular matrix remodeling contribute to the critical processes in the pathogenesis of stroke. In this review, we will also be discussing the role of microRNAs as possible diagnostic and prognostic biomarkers as well as potential therapeutic targets in stroke pathogenesis.


Subject(s)
MicroRNAs/metabolism , Stroke/physiopathology , Animals , Brain Ischemia/physiopathology , Brain Ischemia/therapy , Cerebral Hemorrhage/physiopathology , Cerebral Hemorrhage/therapy , Humans , MicroRNAs/therapeutic use , Risk Factors , Stroke/diagnosis , Stroke/therapy
3.
Eur J Clin Nutr ; 64(12): 1386-92, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20823900

ABSTRACT

BACKGROUND/OBJECTIVES: Excessive consumption of sugar-sweetened beverages (SSBs) increases risk of obesity. Similar data are lacking in Chinese populations with rapid nutritional transition. We aimed to examine the association between SSB intake, lifestyle factors and obesity in Hong Kong Chinese. SUBJECTS/METHODS: This is a cross-sectional survey on SSB intake with 2295 (49.6%) men and 2334 (50.4%) women (age: median 43.0 years, range 18-81 years). They were recruited from a territory-wide health promotion campaign in Hong Kong. All subjects completed a questionnaire and underwent simple health tests. Their SSB intake was based on a 1-week recall (1 unit of SSB=250 ml, frequent SSB consumption=daily intake ≥2 units). RESULTS: Men were more likely than women to smoke, drink alcohol, frequently consumed SSB (20.5 vs 9.5%) and ate more meat portions (2.32±0.57 vs 2.15±0.44) but were physically more active (no exercise: 31.2 vs 39.2%) (P-values: all <0.001). After adjusting for confounding factors, frequent SSB intake remained independently associated with obesity in women (odds ratio (95% confidence interval): 1.86 (1.36-2.55)) while physical inactivity (1.84 (1.41-2.39) for none vs regular), smoking (1.29 (1.05-1.58)) and high daily meat intake (2.15 (1.36, 3.42)) predicted obesity in men. CONCLUSIONS: In Chinese of working age, SSB consumption in women and physical inactivity, smoking and high meat intake in men were associated with obesity.


Subject(s)
Beverages/analysis , Health Promotion , Life Style , Obesity/epidemiology , Sweetening Agents/administration & dosage , Adult , Aged , Aged, 80 and over , Alcohol Drinking/metabolism , Asian People , Cross-Sectional Studies , Female , Hong Kong/epidemiology , Humans , Male , Middle Aged , Motor Activity , Risk Factors , Smoking/metabolism , Surveys and Questionnaires , Young Adult
4.
Neuroscience ; 167(2): 277-86, 2010 May 05.
Article in English | MEDLINE | ID: mdl-20149843

ABSTRACT

Cerebral hypoxia is one of the main causes of cerebral injury. This study was conducted to investigate the potential protective effect of H(2)S in in vitro hypoxic models by subjecting SH-SY5Y cells to either oxygen-glucose deprivation or Na(2)S(2)O(4) (an oxygen scavenger) treatment. We found that treatment with NaHS (an H(2)S donor, 10-100 microM) 15 min prior to hypoxia increased cell viability in a concentration-dependent manner. Time-course study showed that NaHS was able to exert its protective effect even when added 8 h before or less than 4 h after hypoxia induction. Interestingly, endogenous H(2)S level was markedly reduced by hypoxia induction. Over-expression of cystathionine-beta-synthase prevented hypoxia induced cell apoptosis. Blockade of ATP-sensitive K(+) (K(ATP)) channels with glibenclamide and HMR-1098, protein kinase C (PKC) with its three specific inhibitors (chelerythrine, bisindolylmaleide I and calphostin C), extracellular signal-regulated kinase 1/2 (ERK1/2) with PD98059 and heat shock protein 90 (Hsp90) with geldanamycin and radicicol significantly attenuated the protective effects of NaHS. Western blots showed that NaHS significantly stimulated ERK1/2 activation and Hsp90 expression. In conclusion, H(2)S exerts a protective effect against cerebral hypoxia induced neuronal cell death via K(ATP)/PKC/ERK1/2/Hsp90 pathway. Our findings emphasize the important neuroprotective role of H(2)S in the brain during cerebral hypoxia.


Subject(s)
Extracellular Signal-Regulated MAP Kinases/physiology , HSP90 Heat-Shock Proteins/physiology , Hydrogen Sulfide/metabolism , KATP Channels/physiology , Neurons/cytology , Neurotransmitter Agents/metabolism , Protein Kinase C/physiology , Apoptosis , Cell Hypoxia , Cell Line, Tumor , Cell Survival , Humans , Hydrogen Sulfide/pharmacology , Neurons/drug effects , Neurons/metabolism , Neuroprotective Agents/pharmacology , Neurotransmitter Agents/pharmacology , Signal Transduction
5.
Clin Exp Immunol ; 159(1): 11-22, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19843090

ABSTRACT

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease associated with aberrant activation of T and B lymphocytes for the production of inflammatory cytokines and autoreactive antibodies. Animal studies of SLE have indicated that Toll-like receptors (TLR) are important in the pathogenesis of murine lupus. In the present clinical study, differential protein expressions of TLR-1-9 of monocytes and different lymphocyte subsets from patients with SLE and normal control subjects were determined by flow cytometry. Results showed that the expression of intracellular TLRs (TLR-3, -8, -9) and extracellular TLRs (TLR-1, -2, -4, -5, -6) were elevated in monocytes, CD4(+) T lymphocytes, CD8(+) T lymphocytes and B lymphocytes of SLE patients compared to control subjects (all P < 0.001). Moreover, cell surface expression of TLR-4 on CD4(+) T lymphocytes and CD8(+) T lymphocytes, and TLR-6 on B lymphocytes, were correlated positively with SLE disease activity index (SLEDAI) (TLR-4 on CD4(+) T lymphocytes and CD8(+) T lymphocytes: r = 0.536, P = 0.04; r = 0.713, P = 0.003; TLR-6 in B lymphocytes: r = 0.572, P = 0.026). In concordance with the above results, there is an observable increased relative induction (%) of inflammatory cytokine interleukin (IL)-1beta, IL-6, IL-10 and IL-12, chemokines CCL2, CXCL8, CCL5 and CXCL10 from peripheral blood mononuclear cells (PBMC) upon differential stimulation by PolyIC (TLR-3 ligand), lipopolysaccharide (TLR-4 ligand), peptidoglycan (TLR-2 ligand), flagellin (TLR-5 ligand), R837 (TLR-7 ligand) and CpG DNA (TLR-9 ligand) in SLE patients compared to controls. These results suggest that the innate immune response for extracellular pathogens and self-originated DNA plays immunopathological roles via TLR activation in SLE.


Subject(s)
Leukocytes, Mononuclear/metabolism , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/physiopathology , Toll-Like Receptors/metabolism , Adult , Aminoquinolines/pharmacology , B-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/metabolism , Chemokines/metabolism , Dinucleoside Phosphates/pharmacology , Female , Flagellin/pharmacology , Humans , Imiquimod , Immunity, Innate/immunology , Interferon Inducers/pharmacology , Interleukins/metabolism , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Lipopolysaccharides/pharmacology , Lupus Erythematosus, Systemic/diagnosis , Middle Aged , Monocytes/metabolism , Peptidoglycan/pharmacology , Poly I-C/pharmacology , RNA/pharmacology , Severity of Illness Index , Toll-Like Receptors/immunology , Tumor Necrosis Factor-alpha/metabolism , Young Adult
6.
Immunol Invest ; 38(5): 350-64, 2009.
Article in English | MEDLINE | ID: mdl-19811413

ABSTRACT

CD26, a T cell co-stimulatory molecule and dipeptidyl peptidase IV for the degradation of interferon-gamma-induced chemokine, participates in multiple immunopathological roles in leukocyte homing and inflammation. Decreased circulating concentration of soluble (s)CD26 in patients with systemic lupus erythematosus (SLE), rheumatoid arthritis and murine model of arthritis and encephalomyelitis have been reported. In the present study, the plasma concentration of sCD26 and chemokines, and cell surface expression of CD26 on monocytes, CD4+T lymphocytes, CD8+T lymphocytes, CD19+B lymphocytes and invariant natural killer T (iNKT) lymphocytes were analyzed using ELISA and flow cytometry, respectively, in 23 SLE patients and 14 sex- and age-matched control subjects. Although there was no significant difference between plasma concentrations of soluble CD26 in SLE patients with controls (p > 0.05), there was significant elevated Th1 chemokines CXCL10 and CXCL9 but not Th2 chemokine CCL2, and down-regulation in iNKT lymphocytes number and cell surface expression of CD26 on CD4+T and iNKT lymphocytes of SLE patients compared with controls (all p < 0.05). Decreased circulating number of iNKT cells and CD26 on iNKT cells can be important for the immunopathogenesis by exacerbating Th1-related inflammation in SLE.


Subject(s)
Dipeptidyl Peptidase 4/immunology , Lupus Erythematosus, Systemic/immunology , Natural Killer T-Cells/immunology , Th1 Cells/immunology , Adult , Chemokine CCL2/biosynthesis , Chemokine CXCL10/biosynthesis , Chemokine CXCL9/biosynthesis , Dipeptidyl Peptidase 4/biosynthesis , Down-Regulation , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Humans , Lupus Erythematosus, Systemic/metabolism , Natural Killer T-Cells/metabolism , Th1 Cells/metabolism
7.
Immunol Invest ; 38(7): 652-64, 2009.
Article in English | MEDLINE | ID: mdl-19811428

ABSTRACT

A recently identified interleukin (IL)-17-producing T-helper (Th) lymphocyte subset, which comprises Th17 cells producing hallmark cytokines IL-17A, IL-17F and IL-22, is involved in chronic inflammatory diseases. Elevated gene and protein expressions of IL-17 are manifested in allergic asthma. We further characterized the activation of Th17 cells in asthmatic patients. Peripheral blood mononuclear cells (PBMC) were purified from 31 asthmatic patients and 20 sex- and age-matched control subjects. The number of IL-17A secreting cells in peripheral blood was enumerated by enzyme-linked immunosorbent spot assay. Cell surface expression of Th17-related chemokine receptor CCR6, and plasma level of IL-17A, IL-17F and IL-22, and ex vivo production of IL-17A and IL-22 were measured by flow cytometry and enzyme-linked immunosorbent assay, respectively. The number of peripheral Th17 lymphocytes, expression of CCR6 on Th cells, and ex vivo IL-23, anti-CD3 and anti-CD28 induced production of IL-22 by PBMC were significantly elevated in asthmatic patients compared with control subjects (all p < 0.01). This clinical study further confirmed increased number of peripheral Th17 lymphocytes and cell surface expression of CCR6 receptors on Th cells in asthmatic patients. Pro-inflammatory cytokine IL-23 can exacerbate disease severity by activating pathogenic Th17 lymphocytes to release downstream inflammatory cytokine IL-22 in asthma.


Subject(s)
Asthma/blood , Interleukin-17/metabolism , Leukocytes, Mononuclear/metabolism , T-Lymphocytes, Helper-Inducer/metabolism , Adult , Aged , Antibodies, Monoclonal/pharmacology , Asthma/metabolism , Asthma/pathology , CD28 Antigens/immunology , CD3 Complex/immunology , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Humans , Interleukin-17/blood , Interleukin-23/pharmacology , Interleukins/blood , Interleukins/metabolism , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/drug effects , Male , Middle Aged , Receptors, CCR6/metabolism , T-Lymphocytes, Helper-Inducer/cytology , Young Adult , Interleukin-22
8.
Mol Psychiatry ; 14(3): 291-307, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18195718

ABSTRACT

Corticotropin-releasing factor (CRF) and cholecystokinin (CCK), two highly colocalized neuropeptides, have been linked to the etiology of stress-related anxiety disorders. Recent evidence points to the possibility that some of the anxiogenic effects of the central CCK system take place through interplay with the CRF system. The aim of the present study was to examine the effects of chronic, mild activation of CRF receptor 1 (CRF(1)) on the central CCK system of the C57BL/6J mouse. As shown by in situ hybridization, real-Time PCR and immunohistochemistry, 5 days of intracerebroventricular (i.c.v.) injections of a subeffective dose (2.3 pmol) of cortagine, a CRF(1)-selective agonist, resulted in an increase in CCK mRNA levels and CCK(2) receptor immunoreactivity in several brain regions, such as amygdala and hippocampus, known to be involved in the regulation of anxiety. Mice with elevated endogenous central CCK tone exhibited significantly higher anxiety-like behaviors in the open-field task and elevated plus maze, and enhanced conditioned fear. These behavioral changes were reversed by i.c.v. administration of the CCK(2)-selective antagonist LY225910, after 5 days of priming with cortagine. Under the same conditions, the intraperitoneal administration of the CRF(1) antagonist antalarmin was ineffective. This result indicated that once the CCK system was sensitized by prior CRF(1) activation, it exhibited its anxiogenic effects, without influence by CRF(1), possibly because of its observed downregulation. In sum, our results provide a novel model for the interaction of the CRF and CCK systems contributing to the development of hypersensitive emotional circuitry.


Subject(s)
Anxiety/metabolism , Cholecystokinin/metabolism , Conditioning, Classical/physiology , Exploratory Behavior/physiology , Receptors, Corticotropin-Releasing Hormone/physiology , Amygdala/drug effects , Amygdala/metabolism , Animals , Brain/drug effects , Brain/metabolism , Cholecystokinin/genetics , Conditioning, Classical/drug effects , Corticotropin-Releasing Hormone/administration & dosage , Dose-Response Relationship, Drug , Exploratory Behavior/drug effects , Fear , Hippocampus/drug effects , Hippocampus/metabolism , Hormone Antagonists/pharmacology , Injections, Intraventricular , Mice , Mice, Inbred C57BL , Quinazolinones/pharmacology , RNA, Messenger/analysis , Receptor, Cholecystokinin B/antagonists & inhibitors , Receptor, Cholecystokinin B/genetics , Receptor, Cholecystokinin B/metabolism , Receptors, Corticotropin-Releasing Hormone/agonists , Recombinant Fusion Proteins/administration & dosage , Stress, Physiological/physiology
9.
Int J Cardiol ; 136(2): 211-3, 2009 Aug 14.
Article in English | MEDLINE | ID: mdl-18606470

ABSTRACT

The effects of high dose captopril, within the therapeutic range, on autonomic activity are unknown in those with normal cardiovascular function. Thus the study aims were to assess the effects of high dose captopril on autonomic function in mice. Autonomic activity was measured using heart rate variability (HRV). ECG recordings were obtained from 18 Male C57BL/6J mice (20-25 g) subdivided into control (N=8) or mice receiving oral captopril (0.688 mg/ml captopril in the drinking water for 6 weeks, N=10). HRV results for linear and non-linear parameters were attenuated following chronic captopril for 6 weeks compared to control. Captopril was associated with a trend for an increase in average heart rate and approximate entropy (ApEn), a non-linear measure of HRV decreased significantly compared to control (p<0.05). In conclusion high dose captopril reduces total HRV and increases heart rate in normotensive mice with normal cardiac function.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Autonomic Nervous System/drug effects , Captopril/pharmacology , Heart Rate/drug effects , Animals , Male , Mice , Mice, Inbred C57BL
10.
Neuroscience ; 154(3): 1100-6, 2008 Jun 26.
Article in English | MEDLINE | ID: mdl-18501522

ABSTRACT

Statins are increasingly being used for the treatment of a variety of conditions beyond their original indication for cholesterol lowering. We previously reported that simvastatin affected the dopaminergic system in the rat brain. This study aims to investigate regional changes of muscarinic M1/4 receptors in the rat brain after 4-week administration of simvastatin (1 or 10 mg/kg/day). M1/4 receptor distribution and alterations in the post-mortem rat brain were detected by [(3)H]pirenzepine binding autoradiography. Simvastatin (1 mg/kg/day) increased [(3)H]pirenzepine binding, predominantly in the prefrontal cortex (171%, P<0.001), primary motor cortex (153%, P=0.001), cingulate cortex (109%, P<0.001), hippocampus (138%, P<0.001), caudate putamen (122%, P=0.002) and nucleus accumbens (170%, P<0.001) compared with controls; while lower but still significant increases of [(3)H]pirenzepine binding were observed in the examined regions following simvastatin (10 mg/kg/day) treatment. Our results also provide strong evidence that chronic simvastatin administration, especially at a low dosage, up-regulates M1/4 receptor binding, which is likely to be independent of its muscarinic agonist-like effect. Alterations in [(3)H]pirenzepine binding in the examined brain areas may represent the specific regions that mediate the clinical effects of simvastatin treatment on cognition and memory via the muscarinic cholinergic system. These findings contribute to a better understanding of the critical roles of simvastatin in treating neurodegenerative disorders, via muscarinic receptors.


Subject(s)
Brain Chemistry/drug effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Receptor, Muscarinic M1/biosynthesis , Receptor, Muscarinic M4/biosynthesis , Simvastatin/pharmacology , Animals , Autoradiography , Dose-Response Relationship, Drug , Male , Muscarinic Antagonists/metabolism , Muscarinic Antagonists/pharmacology , Pirenzepine/metabolism , Pirenzepine/pharmacology , Rats , Rats, Sprague-Dawley , Up-Regulation/drug effects
11.
Psychopharmacology (Berl) ; 198(2): 251-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18373228

ABSTRACT

RATIONALE: Neuropsychiatric behaviours in Alzheimer's disease (AD) patients have been associated with neocortical alterations of presynaptic cholinergic and muscarinic M2 receptor markers. In contrast, it is unclear whether non-M2 muscarinic receptors have a role to play in AD behavioural symptoms. OBJECTIVES: To correlate the alterations of neocortical postsynaptic muscarinic receptors with clinical features of AD. MATERIALS AND METHODS: [(3)H]4-DAMP were used in binding assays with lysates of Chinese hamster ovary (CHO) cells stably transfected with M1-M5 receptors. [(3)H]4-DAMP was further used to measure muscarinic receptors in the postmortem orbitofrontal cortex of aged controls and AD patients longitudinally assessed for cognitive decline and behavioural symptoms. RESULTS: [(3)H]4-DAMP binds to human postmortem brain homogenates and M1-, M3-, M4- and M5-transfected CHO lysates with subnanomolar affinity. Compared to the controls, the [(3)H]4-DAMP binding density is reduced only in AD patients with significant psychotic symptoms. The association between reduced [(3)H]4-DAMP binding and psychosis is independent of the effects of dementia severity or neurofibrillary tangle burden. CONCLUSIONS: This study suggests that the loss of non-M2 muscarinic receptors in the orbitofrontal cortex may be a neurochemical substrate of psychosis in AD and provides a rationale for further development of muscarinic receptor ligands in AD pharmacotherapy.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/psychology , Muscarinic Antagonists/pharmacology , Neocortex/metabolism , Piperidines/pharmacology , Psychotic Disorders/metabolism , Psychotic Disorders/psychology , Receptors, Muscarinic/drug effects , Aged , Aged, 80 and over , Alzheimer Disease/complications , Animals , CHO Cells , Cohort Studies , Cricetinae , Cricetulus , Female , Humans , Longitudinal Studies , Male , Neocortex/drug effects , Neocortex/pathology , Neurofibrillary Tangles/metabolism , Neurofibrillary Tangles/pathology , Neuropsychological Tests , Psychotic Disorders/complications , Radioligand Assay , Receptor, Muscarinic M2/genetics , Receptor, Muscarinic M2/metabolism , Receptors, Muscarinic/genetics , Synapses/drug effects , Synapses/metabolism , Transfection
12.
Neurochem Int ; 52(1-2): 155-65, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17629356

ABSTRACT

Current evidence suggests that hydrogen sulfide (H2S) plays an important role in brain functions, probably acting as a neuromodulator as well as an intracellular messenger. In the mammalian CNS, H2S is formed from the amino acid cysteine by the action of cystathionine beta-synthase (CBS) with serine (Ser) as the by-product. As CBS is a calcium and calmodulin dependent enzyme, the biosynthesis of H2S should be acutely controlled by the intracellular concentration of calcium. In addition, it is also regulated by S-adenosylmethionine which acts as an allosteric activator of CBS. H2S, as a sulfhydryl compound, has similar reducing properties as glutathione. In neurons, H2S stimulates the production of cAMP probably by direct activation of adenylyl cyclase and thus activate cAMP-dependent processes. In astrocytes, H2S increases intracellular calcium to an extent capable of inducing and propagating a "calcium wave", which is a form of calcium signaling among these cells. Possible physiological functions of H2S include potentiating long-term potentials through activation of the NMDA receptors, regulating the redox status, maintaining the excitatory/inhibitory balance in neurotransmission, and inhibiting oxidative damage through scavenging free radicals and reactive species. H2S is also involved in CNS pathologies such as stroke and Alzheimer's disease. In stroke, H2S appears to act as a mediator of ischemic injuries and thus inhibition of its production has been suggested to be a potential treatment approach in stroke therapy.


Subject(s)
Hydrogen Sulfide/metabolism , Neurons/metabolism , Animals , Brain/metabolism , Central Nervous System Diseases/metabolism , Humans
13.
Neurochem Int ; 50(7-8): 1078-86, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17196711

ABSTRACT

In recent years, there are an increasing number of proteomics studies that investigated the alterations in the protein expression relevant to human diseases but none for stroke. We, therefore, attempted such a study in a paradigm of focal cerebral ischemia in rat. Rats were subjected to cerebral ischemia by unilateral occlusion of the middle cerebral artery. Global protein analysis was performed after 24h on the lesioned and sham-control cerebral cortex using two-dimensional gel electrophoresis. Protein spots with more than a 3-fold change in intensity were identified by mass spectrometry. Middle cerebral artery occlusion (MCAO) caused infarct volume of 18-22% predominantly in the cortex of the lesioned hemisphere. Two-dimensional gel electrophoresis resolved about 1500 protein spots of which only 12 were significantly upregulated by 3-46-fold. Three spots were identified to be dihydropyrimidinase-related protein 2 (DRP-2, also known as collapsin response mediator protein 2 (CRMP-2) or turned on after division, 64 kD protein (TOAD-64)). The spots varied in pI values only and this may reflect different phosphorylation status of the same protein. Two spots were identified as spectrin alpha II chain (rat fragment, also known as alpha-fodrin or non-erythroid alpha chain, SPNA-2); and one spot each for heat shock cognate protein 70 pseudogene 1 (HSC70-ps1, also known as heat shock protein 8 pseudogene 1), and tropomodulin 2 (Tmod2). The upregulation of protein expression was corroborated by observed upregulation of mRNA expression. The remaining five spots were not identified satisfactorily. As DRP-2, spectrin, and Tmod2 are involved in axonal and neurite growth as well as synaptic plasticity and maturation, the presently observed upregulation of the expression of these proteins may indicate active neuroregeneration and repair at 24h after the induction of cerebral ischemia.


Subject(s)
Brain Ischemia/genetics , Brain/physiopathology , Gene Expression Regulation , HSP70 Heat-Shock Proteins/genetics , Intercellular Signaling Peptides and Proteins/genetics , Nerve Tissue Proteins/genetics , Proteomics/methods , Spectrin/genetics , Animals , Brain/enzymology , Disease Models, Animal , Gene Expression Regulation, Enzymologic , Male , Pseudogenes , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction
14.
Int J Obes (Lond) ; 31(2): 254-60, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16718283

ABSTRACT

OBJECTIVE: To study the inter-relationships between sleeping hours, working hours and obesity in subjects from a working population. RESEARCH DESIGN: A cross-sectional observation study under the 'Better Health for Better Hong Kong' Campaign, which is a territory-wide health awareness and promotion program. SUBJECTS: 4793 subjects (2353 (49.1%) men and 2440 (50.9%) women). Their mean age (+/-s.d.) was 42.4+/-8.9 years (range 17-83 years, median 43.0 years). Subjects were randomly selected using computer-generated codes in accordance to the distribution of occupational groups in Hong Kong. RESULTS: The mean daily sleeping time was 7.06+/-1.03 h (women vs men: 7.14+/-1.08 h vs 6.98+/-0.96 h, P<0.001). Increasing body mass index (BMI) was associated with reducing number of sleeping hours and increasing number of working hours reaching significance in the whole group as well as among male subjects. Those with short sleeping hour (6 h or less) and long working hours (>9 h) had the highest BMI and waist in both men and women. Based on multiple regression analysis with age, smoking, alcohol drinking, systolic and diastolic blood pressure, mean daily sleeping hours and working hours as independent variables, BMI was independently associated with age, systolic and diastolic blood pressure in women, whereas waist was associated with age, smoking and blood pressure. In men, blood pressure, sleeping hours and working hours were independently associated with BMI, whereas waist was independently associated with age, smoking, blood pressure, sleeping hours and working hours in men. CONCLUSION: Obesity is associated with reduced sleeping hours and long working hours in men among Hong Kong Chinese working population. Further studies are needed to investigate the underlying mechanisms of this relationship and its potential implication on prevention and management of obesity.


Subject(s)
Employment , Health Promotion , Obesity/etiology , Sleep , Adolescent , Adult , Aged , Aged, 80 and over , Blood Pressure , Body Mass Index , Female , Hong Kong/epidemiology , Humans , Male , Middle Aged , Obesity/ethnology , Obesity/prevention & control , Personnel Staffing and Scheduling/statistics & numerical data , Time Factors
15.
Int J Gynecol Cancer ; 16(2): 814-20, 2006.
Article in English | MEDLINE | ID: mdl-16681767

ABSTRACT

The purpose of the study was to evaluate tamoxifen-associated changes in the vagina and uterus in postmenopausal breast cancer patients. Between June 1994 and December 1998, 45 patients enrolled in a prospective study before commencing tamoxifen therapy. Patients with endometrial thickness >5 mm or neoplasia were excluded. Transvaginal ultrasonography, vaginal maturation indexes (VMI), and endometrial biopsy were performed at baseline and repeated at 6 months (n= 42), 1 year (n= 39), 2 years (n= 32), 3 years (n= 26), 4 years (n= 19), and 5 years (n= 15). For the 39 patients followed for 1 year, VMI (% parabasal/intermediate/superficial) was 21/71/8 at baseline compared with 1/90/9 at 1 year (P value = 0.0008/0.001/0.78). At baseline, mean endometrial thickness and uterine volume were 2.6 mm and 64 cm(3), respectively, compared with 5.8 mm and 84 cm(3) at 1 year (P= 0.0002, 0.002). At baseline, 80% of patients had atrophic endometrium and 9% proliferative endometrium compared with 61% and 26% at 1 year, respectively (P= 0.04). No cases of endometrial hyperplasia or adenocarcinoma were detected. Findings observed at 6 months persisted through 5 years of follow-up. Tamoxifen exerts a weak estrogenic effect on the vagina and uterus in highly prescreened postmenopausal women without preexisting endometrial pathology.


Subject(s)
Antineoplastic Agents, Hormonal/therapeutic use , Breast Neoplasms/drug therapy , Postmenopause , Tamoxifen/therapeutic use , Uterus/drug effects , Adult , Aged , Aged, 80 and over , Endometrium/drug effects , Female , Humans , Middle Aged , Postmenopause/drug effects , Postmenopause/physiology , Prospective Studies
16.
Brain Res ; 1045(1-2): 229-33, 2005 May 31.
Article in English | MEDLINE | ID: mdl-15910782

ABSTRACT

Sprague-Dawley rats with unilateral lesion of the medial forebrain bundle by 6-hydroxydopamine showed marked decrease in the expression of dopamine D1 and D2 receptors in the prefrontal cortex. Simvastatin (10 mg/kg/day for 4 weeks) restored receptor expression to control levels. Given the association of dopaminergic dysfunction in the prefrontal cortex and cognitive deficits in Parkinson's disease, these findings may have implication in the treatment of cognitive decline in advanced Parkinson's disease.


Subject(s)
Parkinsonian Disorders/drug therapy , Prefrontal Cortex/drug effects , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D2/metabolism , Simvastatin/pharmacology , Animals , Cognition Disorders/drug therapy , Cognition Disorders/etiology , Cognition Disorders/metabolism , Disease Models, Animal , Down-Regulation/drug effects , Down-Regulation/physiology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Male , Medial Forebrain Bundle/drug effects , Medial Forebrain Bundle/metabolism , Medial Forebrain Bundle/physiopathology , Oxidopamine , Parkinsonian Disorders/metabolism , Parkinsonian Disorders/physiopathology , Prefrontal Cortex/metabolism , Prefrontal Cortex/physiopathology , Rats , Rats, Sprague-Dawley , Recovery of Function/drug effects , Recovery of Function/physiology , Substantia Nigra/drug effects , Substantia Nigra/metabolism , Substantia Nigra/physiopathology , Sympatholytics , Treatment Outcome
17.
Neuroscience ; 129(2): 337-47, 2004.
Article in English | MEDLINE | ID: mdl-15501591

ABSTRACT

The relationship between running, glial cell activation and pro-inflammatory cytokines was studied in the context of neuroprotection against ischemic stroke induced by middle cerebral artery occlusion (MCAO). This was investigated in four groups of rats, namely, (1) nonrunner, (2) runner after 12 weeks of treadmill running, (3) nonrunner with MCAO and (4) runner with MCAO. The horizontal diagonal band of Broca (HDB) in the septum was scrutinized for qualitative cum quantitative changes in the microglia and astrocytes. Reverse transcription-polymerase chain reaction and immunoblot work were carried out in the forebrain homogenate to determine, respectively, the gene and protein expression of several pro-inflammatory cytokines. Our results indicated that the runner exhibited less immunoreactivity and reduced numbers of glial cells within the HDB compared with the nonrunner. Interestingly, the mRNA and protein levels of tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6 and interferon-gamma, were significantly downregulated in the runner. Our data also suggest albeit with some inconsistency that the runner/MCAO rats had benefited from running. These observations suggest that running can result in changes to the microenvironment, in which the microglia and astrocytes exist in a state of quiescence concomitant with a reduced expression of pro-inflammatory cytokines, that may lead to beneficial effects seen in ischemic stroke induced by MCAO.


Subject(s)
Cytokines/metabolism , Diagonal Band of Broca/metabolism , Macrophage Activation/physiology , Microglia/metabolism , Physical Exertion/physiology , Running/physiology , Septum of Brain/metabolism , Stroke/metabolism , Animals , Astrocytes/physiology , Astrocytes/ultrastructure , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Immunoblotting , Immunohistochemistry , Infarction, Middle Cerebral Artery/complications , Infarction, Middle Cerebral Artery/physiopathology , Male , Microglia/pathology , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction
18.
Neurosci Lett ; 358(3): 215-9, 2004 Apr 01.
Article in English | MEDLINE | ID: mdl-15039119

ABSTRACT

This study investigated the behavioral mechanisms underlying the anxiogenic, or anxiolytic mediated effects of CCK(2) receptor mediated agonist (CCK-4) and antagonist drugs (LY225910, LY288513, CR2945) in PVG hooded and Sprague-Dawley (SD) rats using the elevated plus maze test apparatus. In addition, the effects of a CCK(1) antagonist (CR1409) were investigated for its possible mediation in anxiety behavior between PVG hooded and SD rats. PVG hooded rats treated with CCK-4, decreased the time spent in the open arm and increased the time spent in the closed arm and correspondingly showed increase in the number of entries in the open arms while the number of entries in closed arm was insignificant, whereas SD rats decreased the time spent in the closed arm, while other parameters remained insignificant. PVG hooded rats administered with various CCK(2) antagonists (LY225910, LY288513, and CR2945) significantly increased the time spent in the open arm and correspondingly decreased the time spent in the closed arm, while the number of entries in the open or closed arm was insignificant, in contrast, SD rats failed to show any reliable significance. PVG hooded rats administered with the CCK(1) antagonist (CR1409), failed to show any reliable significance, in contrast, SD rats significantly increased the time spent in the open arm. The strain differences observed in this study suggests that CCK plays mainly as a neuromodulator, in which the various CCK(2) antagonists may not affect baseline anxiety state, but instead they modulate heightened states of anxiety through differential effects of CCK(1)/CCK(2) receptors.


Subject(s)
Anti-Anxiety Agents/pharmacology , Anxiety/metabolism , Brain/metabolism , Cholecystokinin/metabolism , Proglumide/analogs & derivatives , Receptors, Cholecystokinin/metabolism , Species Specificity , Animals , Anxiety/chemically induced , Anxiety/drug therapy , Behavior, Animal/drug effects , Behavior, Animal/physiology , Benzodiazepines , Brain/drug effects , Chemokines/agonists , Chemokines/antagonists & inhibitors , Chemokines/metabolism , Chemokines, CC , Cholecystokinin/agonists , Cholecystokinin/antagonists & inhibitors , Male , Maze Learning/drug effects , Maze Learning/physiology , Proglumide/pharmacology , Pyrazoles/pharmacology , Quinazolines/pharmacology , Quinazolinones , Rats , Rats, Sprague-Dawley , Receptor, Cholecystokinin B/agonists , Receptor, Cholecystokinin B/antagonists & inhibitors , Receptor, Cholecystokinin B/metabolism , Receptors, Cholecystokinin/agonists , Receptors, Cholecystokinin/antagonists & inhibitors , Tetragastrin/pharmacology
19.
Neurosci Lett ; 355(3): 205-8, 2004 Jan 30.
Article in English | MEDLINE | ID: mdl-14732467

ABSTRACT

Our previous studies (NeuroReport 12 (2001) 2717) showed that PVG hooded and not Sprague-Dawley (SD) rats exhibit remarkable freezing behavior on exposure to a cat in the cat freezing test apparatus. In the present study, we further examined the differences between these two strains of rats in response to repeated daily exposure to a cat in the cat freezing test apparatus. Freezing behavior habituation was observed in both PVG hooded (days 5-7) and SD rats (days 3-7). A selective CCK(2) agonist (BC264, 0.3 microg/kg, i.p.) on day 8 reversed habituated freezing behavior and locomotor activity in PVG hooded rats, but not in SD rats. These results suggest that CCK2 receptors mediate habituation to an anxiety-inducing stimulus in PVG hooded rats and further suggest that differential expression of these CCK2 receptors underlies this strain difference.


Subject(s)
Cholecystokinin/analogs & derivatives , Cholecystokinin/pharmacology , Habituation, Psychophysiologic/drug effects , Immobilization/physiology , Motor Activity/drug effects , Peptide Fragments/pharmacology , Receptor, Cholecystokinin B/agonists , Animals , Cats , Habituation, Psychophysiologic/physiology , Male , Motor Activity/physiology , Rats , Rats, Sprague-Dawley , Receptor, Cholecystokinin B/physiology , Species Specificity
20.
Neurosci Lett ; 354(2): 139-42, 2004 Jan 09.
Article in English | MEDLINE | ID: mdl-14698458

ABSTRACT

The periaqueductal gray (PAG) is considered to be an exit relay for defensive responses. Studies have shown that the ventrolateral periaqueductal gray (vlPAG) plays a role in the expression of freezing behavior whereas dorsolateral periaqueductal gray (dlPAG) is involved on both freezing and active forms of defensive behaviors. To further elucidate this theory, lesioned vlPAG and dlPAG rats were exposed to a cat in the cat-freezing test apparatus. Subsequently, a 7-day repeated exposure to a cat was done on the vlPAG and dlPAG lesioned rats. Results showed that the vlPAG lesioned rats demonstrated significant decrease in freezing behavior and corresponding increase in locomotor activity, while the dlPAG lesioned rats failed to show any significance. Subsequent repeated exposure of the vlPAG lesioned rats to a cat for 7 days showed a gradual decrease in freezing behavior with significance shown at days 5, 6 and 7 while the dlPAG lesioned rats failed to show any changes. These results suggest that vlPAG regulates freezing behavior in hooded PVG rats.


Subject(s)
Behavior, Animal/physiology , Fear/physiology , Neural Pathways/physiology , Periaqueductal Gray/physiology , Animals , Axotomy , Cats , Habituation, Psychophysiologic/physiology , Male , Motor Activity/physiology , Neural Pathways/cytology , Periaqueductal Gray/cytology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...